News
Using its proprietary FBDD platform, Blacksmith discovered FG-2101, the prodrug form of FG-960, the first known non-hydroxamate LpxC inhibitor that exerted activity against LpxC at the nanomolar range ...
However, weak free cash flow combined with negative momentum in the stock led to shares falling 7% in early trading. We are lowering our fair value estimate 5% to EUR 80 from EUR 84 after ...
Accelerate Diagnostics, Inc., an innovator in rapid in vitro diagnostics for microbiology, announced the submission of its Accelerate WAVE system and positive blood culture gram-negative test kit to ...
today announced the submission of its Accelerate WAVE™ system and positive blood culture gram-negative test kit to the U.S. Food and Drug Administration (FDA) for 510(k) clearance. The ...
TUCSON, Ariz., March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results